Stock DN DELTA 9 CANNABIS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Delta 9 Cannabis Inc.

Equities

DN

CA2477541049

Pharmaceuticals

Delayed Toronto S.E.
Other stock markets
 11:02:59 2024-04-25 am EDT 		5-day change 1st Jan Change
0.025 CAD 0.00% Intraday chart for Delta 9 Cannabis Inc. 0.00% 0.00%
Apr. 01 Delta 9 Cannabis to Seek Cannabis Stores Acquisition CI
Apr. 01 Transcript : Delta 9 Cannabis Inc., 2023 Earnings Call, Apr 01, 2024

Business Summary

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.

Number of employees: 320

Sales per Business

CAD in Million2022Weight2023Weight Delta
Retail Cannabis and Merchandise and Devices
86.1 %
52 82.8 % 61 86.1 % +16.92%
Wholesale Cannabis
11.4 %
9 14.1 % 8 11.4 % -8.74%
Business to Business
2.4 %
2 3.1 % 2 2.4 % -12.39%

Sales per region

CAD in Million2022Weight2023Weight Delta
Canada
100.0 %
63 100.0 % 71 100.0 % +12.39%

Managers

Managers TitleAgeSince
John Arbuthnot CEO
 Chief Executive Officer 34 11-12-31
James Lawson DFI
 Director of Finance/CFO 73 -
Todd Schubert CTO
 Chief Tech/Sci/R&D Officer - -
Mark Jonker COO
 Chief Operating Officer - 19-07-31
John Arbuthnot BRD
 Director/Board Member 70 11-12-31
Ian Chadsey IRC
 Investor Relations Contact - 18-12-31
Kelsey Friesen SAM
 Sales & Marketing - -
Marshall Posner SAM
 Sales & Marketing - -
David Kideckel PRN
 Corporate Officer/Principal - 21-08-15

Members of the board

Members of the board TitleAgeSince
Hugh Aird BRD
 Director/Board Member 70 18-09-06
Nitin Kaushal CHM
 Chairman 58 17-10-30
John Arbuthnot CEO
 Chief Executive Officer 34 11-12-31
John Arbuthnot BRD
 Director/Board Member 70 11-12-31
Stuart Starkey BRD
 Director/Board Member - 22-12-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 261,621,645 219,483,528 ( 83.89 %) 0 83.89 %

Shareholders

NameEquities%Valuation
John Arbuthnot
7.067 %
18,489,750 7.067 % 683 196 $
John Arbuthnot
5.304 %
13,877,500 5.304 % 512 774 $
10552763 Canada Corp.
2.738 %
7,163,650 2.738 % 264 697 $
Nitin Kaushal
2.064 %
5,400,000 2.064 % 199 530 $
Stuart Starkey
1.725 %
4,513,205 1.725 % 166 763 $
Hugh Aird
1.310 %
3,426,667 1.310 % 126 615 $
James Lawson
0.5890 %
1,540,963 0.5890 % 56 939 $
Mark Jonker
0.4070 %
1,064,845 0.4070 % 39 346 $

Company contact information

Delta 9 Cannabis, Inc.

Osborne Village

R3L 2V9, Winnipeg

+

http://www.delta9.ca
address Delta 9 Cannabis Inc.(DN)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.025 CAD
Average target price
0.06 CAD
Spread / Average Target
+140.00%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
DELTA 9 CANNABIS INC. Stock Delta 9 Cannabis Inc.
0.00% 5.27M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.17% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.31% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.75% 322B
ABBVIE INC. Stock AbbVie Inc.
+7.64% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.47% 219B
NOVARTIS AG Stock Novartis AG
+6.06% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.35% 196B
PFIZER, INC. Stock Pfizer, Inc.
-11.24% 149B
AMGEN INC. Stock Amgen Inc.
-6.73% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. DN Stock
  4. Company Delta 9 Cannabis Inc.